Skip to main content

Home

Be confident that your patient care is up to date

Springer Medicine provides trustworthy, tailored, cutting‑edge content for medical professionals 

Selecting critical updates; keeping you informed; saving you time

Why register?  Our editorial team filters the most critical updates into tailored newsletters that deliver bitesize news, webinars, and CME direct to your inbox.  » Learn more

Editor's Choice

Oral infigratinib shows promise in achondroplasia

Once-daily oral infigratinib increases growth rate, with minimal side effects in children with achondroplasia.

Type 1 diabetes and glucose control during labour and delivery

An update on diabetes management during labour and delivery in women with type 1 diabetes, focusing on insulin administration, carbohydrate supply, and the use of diabetes technology.

Vaping and tumor metastasis

Cigarette smoking is known to promote tumor metastasis, but do e-cigarettes also have an impact? This mini review synthesizes the current literature on the topic and discusses potential public health implications.

Novel CAR T-cell therapy shows potential for B-cell ALL

Obecabtagene autoleucel has demonstrated promising antitumor activity and safety in adults with relapsed or refractory B-cell acute lymphoblastic leukemia.

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now
SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

  • Webinar | 03-12-2024 | 19:00 (CET)

Join us for an insightful session tailored for pulmonologists and healthcaree professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies. 

On-demand version coming soon

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Learn more

Latest CME and eLearning

Webcast (Link opens in a new window)

1.0 Interprofessional Continuing Education (IPCE) credit, 1.0 AAPA Category 1 CME credits

DMD remains a progressive incurable disease, but advances in patient-centered care and treatment for cardiopulmonary dysfunction have helped to increase life expectancy. This program equips multidisciplinary teams, including pediatric neurologists, pediatricians, pulmonologists, cardiologists, and endocrinologists, with key knowledge and skills to enhance care throughout the patient journey.

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME

Patient Cases

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

Developed by: Springer Medizin

Symposium (Link opens in a new window)

An independent symposium at the 10th COMy World Congress focusing on BCMA-targeting strategies for the treatment of multiple myeloma. Gain insights into the latest clinical data and the implications for clinical practice.

Supported by:
  • GlaxoSmithKline
Developed by: Springer Healthcare IME

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

Latest Open Access Reviews

A Decades-Long Journey of Palmitoylethanolamide (PEA) for Chronic Neuropathic Pain Management: A Comprehensive Narrative Review

  • Open Access
  • REVIEW

Palmitoylethanolamide (PEA) has been prescribed in neuropathic pain management for over 20 years. This study aims to summarize what has been published on the topic in the last 15 years and determine the appropriateness of the prescribing. It …

Sex Differences in Parkinson’s Disease: A Narrative Review

  • Open Access
  • REVIEW

Sex differences in epidemiology, clinical features, and therapeutical responses are emerging in several movement disorders, even though they are still not widely recognized. Parkinson’s disease (PD) is not an exception: men and women suffering …

Comparative Analysis of Stent-Assisted Versus Non-Stent-Assisted Coiling in the Management of Ruptured Intracranial Aneurysms: A Systematic Review and Meta-Analysis

  • Open Access
  • Review

Intracranial aneurysms (IA) present as localized pathological dilatations of the arterial walls within the cranium. The rupture of IA is associated with 50–80% of subarachnoid hemorrhage (SAH), leading to a mortality rate of up to 40% within the …

Senolytics: charting a new course or enhancing existing anti-tumor therapies?

  • Open Access
  • Review

Cell senescence is a natural response within our organisms. Initially, it was considered an effective anti-tumor mechanism. However, it is now believed that while cell senescence initially acts as a robust barrier against tumor initiation, the …

Episode 13: Advances in MASLD and MASH

Welcoming a new name and a new treatment

Metabolic dysfunction-associated liver disease is a significant healthcare concern and burden. Until recently there was no approved pharmacologic treatment for the more serious form of the disease, metabolic dysfunction-associated steatohepatitis. 

In this wide-ranging conversation, Prof. Vlad Ratziu explains the rationale behind the recently updated subclassification and nomenclature for steatotic liver disease, puts the therapeutic advance of resmetirom into context, and looks to the future for MASLD and MASH.

Prof. Vlad Ratziu
Listen now

About Springer Medicine

Better-informed doctors make better decisions. Which is why we’ve launched Springer Medicine, a pan-European, English-language, medical education platform. Our mission is to educate doctors on the latest clinical advances, so you can offer your patients the best possible care. 

Building on Springer Nature’s reputation as a guardian of scientific knowledge and thought-leadership, using our comprehensive wealth of clinical content and established relationships with international experts, Springer Medicine is committed to empowering you with the knowledge you need for your patients. 

» Learn more about our mission

Listen to the Medicine Matters Podcast

Medicine Matters is a pan-specialty podcast for doctors, that discusses the most exciting, controversial, and practice-changing topics across medical practice as a whole. In our episodes, we talk to leading clinical experts, to researchers and funding institutes, and to industry partners about the well-known and perhaps the lesser-known issues affecting doctors in their clinics. We examine everything from new drug approvals to social issues affecting medicine, challenging some of the status quo along the way.

You can also subscribe via:  Spotify | Apple Podcasts | Deezer

Browse episodes

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team